A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Tolerability of 3VM1001 Cream for the Treatment of Pain Associated With Post-Herpetic Neuralgia: A Proof of Concept Study
Latest Information Update: 17 Jul 2018
At a glance
- Drugs 3VM 1001 (Primary)
- Indications Postherpetic neuralgia
- Focus Proof of concept; Therapeutic Use
- Sponsors CDA Research Group
Most Recent Events
- 09 Jul 2018 Status changed from recruiting to completed.
- 07 Feb 2018 New trial record